Benchmark Medication Error
Contents |
is the definition of a medication error? What are the “ten key elements” of the medication-use system? Won’t medication errors be prevented if nurses just follow the “Five Rights?” What are "high-alert" medications? What abbreviations are dangerous? Are these evidence based? rate of medication errors in hospitals What drug names are frequently confused? How should tall man lettering be applied to differentiate medication error rate calculation look-alike/sound-alike drug names? What is confirmation bias? How do I do an independent double check? How can I measure culture? Should a national average medication error rate healthcare practitioner be disciplined for being involved in an error? How can I assess risk? What is the difference between high-leverage and low-leverage safety strategies? What is an FMEA, and how can I use it? How do benchmark data for medication errors I join ISMP? What ISMP resources are available for consumers? Why are standard concentrations safer than using the Rule of 6 for pediatric drips? What tools does ISMP have to satisfy regulatory or insurance network inclusion requirements for community pharmacies to demonstrate participation and knowledge in medication safe practices? Is there a way to get involved with ISMP as a student? Does ISMP have a nationally registered student-organization? 1. What is the national medication
Medication Error Statistics 2015
error rate? What standards are available for benchmarking? A national or other regional medication error rate does not exist. It is not possible to establish a national medication error rate or set a benchmark for medication error rates. Each hospital or organization is different. The rates that are tracked are a measure of the number of reports at a given institution not the actual number of events or the quality of the care given. Most systems for measuring medication errors rely on voluntary reporting of errors and near-miss events. Studies have shown that even in good systems, voluntary reporting only captures the "tip of the iceberg." For this reason, counting reported errors yields limited information about how safe a medication-use process actually is. It is very possible that an institution with a good reporting system, and thus what appears to be a high error "rate," may have a safer system. For more detailed information see Medication Errors, a book available on our website, and the following articles. "If safety is your yardstick, measuring culture from the top down must be a priority" ISMP Medication Safety Alert! March 22, 2007 "Measuring up to medication safety" ISMP Medication Safety Alert! March 10, 2005 "Measuring medication safety: What works? What doesn't?" ISMP Medication Safety Alert! Aug. 11, 1999 "Four-pronged error analysis is "best
Know Governance Job Openings Login to PA-PSRS About PA-PSRS Data Interface Facility Reporting Information Login to PassKey About PassKey Advisory Library Patient and
Medication Error Definition
Consumer Tips Press Releases Healthcare-Associated Infections Brochures Related Organization Links The medication errors statistics Authority in the News Driving Change Patient Safety Tools Calendar Public Meetings ADDRESS: Patient Safety Authority medication errors in nursing 333 Market Street Lobby Level Harrisburg, PA 17120 Phone: 717-346-0469 Fax: 717-346-1090 SearchAdvanced Search Understanding the Benchmarking Process PA PSRS Patient Saf Advis 2004 Dec;1(4):19. http://www.ismp.org/faq.asp _______________This article is excerpted from the book Medication Errors by Michael Cohen, RPh, MS, ScD. Dr. Cohen is President of the Institute for Safe Medication Practices (ISMP) and serves as an expert advisor to PA-PSRS in the area of medication safety._______________Benchmarking is an ongoing process that determines how other organizations have achieved optimal http://patientsafetyauthority.org/ADVISORIES/AdvisoryLibrary/2004/dec1(4)/Pages/19.aspx performance. Through the process of benchmarking, ways are suggested for adapting the best practices that result in exception performance. Although measurement is one of its components, effective benchmarking is a dual process that requires two products: performance measurement and enablers.Benchmarks are measures of comparative performance that answer the question: What is your level of performance? By itself, this information has little use in improving performance. To be effective, benchmarking must also provide a systematic method of understanding the underlying process that determines an organization’s performance. To that end, enablers must be identified. Enablers are the specific practices that lead to exemplary performance; they answer the question: How do you do it? Overlooking either one of these components in the benchmarking process renders it useless, even dangerous.Although medication error rates, for example, may seem ideal for benchmarking, we must question the wisdom of applying the benchmarking concept to the medication use process when the focus is on error rates. Certai
Health Search databasePMCAll DatabasesAssemblyBioProjectBioSampleBioSystemsBooksClinVarCloneConserved DomainsdbGaPdbVarESTGeneGenomeGEO DataSetsGEO ProfilesGSSGTRHomoloGeneMedGenMeSHNCBI Web SiteNLM CatalogNucleotideOMIMPMCPopSetProbeProteinProtein ClustersPubChem BioAssayPubChem CompoundPubChem SubstancePubMedPubMed HealthSNPSRAStructureTaxonomyToolKitToolKitAllToolKitBookToolKitBookghUniGeneSearch termSearch Advanced Journal list Help Journal ListAnn Intensive Carev.2; 2012PMC3310841 Ann Intensive Care. 2012; 2: 2. Published medication error online 2012 Feb 16. doi: 10.1186/2110-5820-2-2PMCID: PMC3310841Overview of medical errors and adverse eventsMaité Garrouste-Orgeas,1,2 François Philippart,1,3,4 Cédric Bruel,1 Adeline Max,1 Nicolas Lau,1 and B Misset1,31Réanimation médico-chirurgicale, Groupe Hospitalier Paris Saint Joseph, Paris, medication errors in France2Université Joseph Fourier, Unité INSERM, Epidémiologie des cancers et des maladies sévères, Institut Albert Bonniot, La Tronche, France3Medicine Faculty, Université Paris Descartes, Paris, France4Infection and Epidemiology department Pasteur Institut, Paris, FranceCorresponding author.Maité Garrouste-Orgeas: rf.jsph@etsuorragm; François Philippart: rf.jsph@trappilihpf; Cédric Bruel: rf.jsph@leurbc; Adeline Max: rf.jsph@xama; Nicolas Lau: rf.jsph@ualn; B Misset: rf.jsph@tessimb Author information ► Article notes ► Copyright and License information ►Received 2011 Sep 30; Accepted 2012 Feb 16.Copyright ©2012 Garrouste-Orgeas et al; licensee Springer.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
be down. Please try the request again. Your cache administrator is webmaster. Generated Sun, 02 Oct 2016 08:04:54 GMT by s_hv1002 (squid/3.5.20)